IM Cannabis (IMCC) Return on Invested Capital (2021 - 2025)
IM Cannabis' (IMCC) quarterly Return on Invested Capital came in at 0.01% in Q4 2025, up 1.0% year-on-year from 0.01% in Q4 2024, and up 30.84% quarter-over-quarter from 0.01% in Q3 2025.
IM Cannabis (IMCC) Return on Invested Capital (2021 - 2025) Analysis & Trends
IM Cannabis' Return on Invested Capital history runs 5 years deep, the most recent figure standing at 0.01% for Q4 2025.
- On a quarterly basis, Return on Invested Capital rose 1.0% year-over-year to 0.01% in Q4 2025; TTM through Dec 2025 was 0.01%, a 1.0% increase from a year earlier, with the FY2025 full-year figure at 0.01%, changed 0.0% from the prior year.
- Return on Invested Capital climbed to 0.01% in Q4 2025 per IMCC's latest filing, from 0.01% in the prior quarter.
- Across five years, Return on Invested Capital topped out at 0.01% in Q2 2025 and bottomed at 0.26% in Q4 2022.
- The 5-year median for Return on Invested Capital is 0.02% (2022), against an average of 0.05%.
- Across the five-year window, Return on Invested Capital slipped 23 bps in 2022 and advanced 25 bps in 2023, its largest moves.
- Year by year, Return on Invested Capital stood at 0.03% in 2021, then tumbled by 730 bps to 0.26% in 2022, then soared by 96 bps to 0.01% in 2023, then plunged by 120 bps to 0.02% in 2024, then soared by 65 bps to 0.01% in 2025.
- Per Business Quant, the three latest IMCC Return on Invested Capital figures stand at 0.01% (Q4 2025), 0.01% (Q3 2025), and 0.01% (Q2 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROIC (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 0.01% |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 0.01% |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 0.00% |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | - |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 0.00% |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | - |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 0.03% |
| 10 | IM Cannabis | 591,792.44 | -193,562.09 | 1.03 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -0.01% |
| Sep 30, 2025 | -0.01% |
| Jun 30, 2025 | -0.01% |
| Dec 31, 2024 | -0.02% |
| Sep 30, 2024 | -0.01% |
| Jun 30, 2024 | -0.01% |
| Dec 31, 2023 | -0.01% |
| Sep 30, 2023 | -0.07% |
| Dec 31, 2022 | -0.26% |
| Sep 30, 2022 | -0.14% |
| Jun 30, 2022 | -0.03% |
| Mar 31, 2022 | -0.02% |
| Dec 31, 2021 | -0.03% |